Companion Animals

Dog Immune Thrombocytopenia: Bleeding Risk and Welfare

Immune thrombocytopenia (ITP) is a serious autoimmune condition causing dangerously low platelet counts in dogs, creating life-threatening bleeding risk that requires prompt and often intensive treatment.

Key Facts

Welfare Considerations

ITP causes both acute crisis suffering and prolonged treatment-related welfare impacts. The presentation of spontaneous bleeding — petechiae appearing over the skin, blood from mucous membranes or nose, sudden collapse from internal haemorrhage — is frightening and acutely distressing. Internal haemorrhage into joints causes severe pain; intracranial bleeding causes neurological emergency. Dogs with severe ITP must be strictly rested to prevent traumatic haemorrhage — even minor bumps can trigger significant bleeding when platelet counts are critically low. The treatment course is lengthy: high-dose prednisolone causes steroid side effects (polydipsia, polyuria, muscle wasting, behavioural changes) that persist throughout the weeks-to-months treatment period. Vincristine infusion requires IV catheter placement in already bruised, fragile-veined patients. The unpredictability of relapse creates chronic owner anxiety and repeated periods of intensive monitoring. Despite all this, successful remission produces genuinely excellent quality of life between episodes.

What You Can Do